Biblio

Export 326 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
Journal Article
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., “Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., “Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
A. Di Carlo, Baldereschi, M., Lamassa, M., Bovis, F., Inzitari, M., Solfrizzi, V., Panza, F., Galluzzo, L., Scafato, E., and Inzitari, D., “Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 505-15, 2016.
L. Iaccarino, Chiotis, K., Alongi, P., Almkvist, O., Wall, A., Cerami, C., Bettinardi, V., Gianolli, L., Nordberg, A., and Perani, D., “A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.”, J Alzheimers Dis, vol. 59, no. 2, pp. 603-614, 2017.
N. Saji, Ishihara, Y., Murotani, K., Uchiyama, A., Takeda, A., Sakurai, T., and Matsushita, K., “Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.”, J Alzheimers Dis, vol. 96, no. 1, pp. 369-380, 2023.
N. Baazaoui and Iqbal, K., “COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences.”, J Alzheimers Dis, vol. 88, no. 2, pp. 399-416, 2022.
M. Nakanishi, Igarashi, A., Ueda, K., Brnabic, A. J. M., Treuer, T., Sato, M., Kahle-Wrobleski, K., Meguro, K., Yamada, M., Mimura, M., and Arai, H., “Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 127-138, 2020.
A. Subotic, McCreary, C. R., Saad, F., Nguyen, A., Alvarez-Veronesi, A., Zwiers, A. M., Charlton, A., Beaudin, A. E., Ismail, Z., G Pike, B., and Smith, E. E., “Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1663-1671, 2021.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
K. Nho, Ramanan, V. K., Horgusluoglu, E., Kim, S., Inlow, M. H., Risacher, S. L., McDonald, B. C., Farlow, M. R., Foroud, T. M., Gao, S., Callahan, C. M., Hendrie, H. C., Niculescu, A. B., and Saykin, A. J., “Comprehensive Gene- and Pathway-Based Analysis of Depressive Symptoms in Older Adults.”, J Alzheimers Dis, 2015.
A. Medoro, Bartollino, S., Mignogna, D., Passarella, D., Porcile, C., Pagano, A., Florio, T., Nizzari, M., Guerra, G., Di Marco, R., Intrieri, M., Raimo, G., and Russo, C., “Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.”, J Alzheimers Dis, vol. 61, no. 1, pp. 1-15, 2018.
A. Niwa, Ii, Y., Shindo, A., Matsuo, K., Ishikawa, H., Taniguchi, A., Takase, S., Maeda, M., Sakuma, H., Akatsu, H., Hashizume, Y., and Tomimoto, H., “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
A. Niwa, Ii, Y., Shindo, A., Matsuo, K., Ishikawa, H., Taniguchi, A., Takase, S., Maeda, M., Sakuma, H., Akatsu, H., Hashizume, Y., and Tomimoto, H., “Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology.”, J Alzheimers Dis, vol. 59, no. 3, pp. 951-959, 2017.
A. Dodich, Cerami, C., Cappa, S. F., Marcone, A., Golzi, V., Zamboni, M., Giusti, M. Cristina, and Iannaccone, S., “Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.”, J Alzheimers Dis, vol. 61, no. 2, pp. 761-772, 2018.
S. Matsunaga, Kishi, T., and Iwata, N., “Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1229-1239, 2017.
T. Kishi, Matsuda, Y., and Iwata, N., “Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.”, J Alzheimers Dis, vol. 64, no. 1, pp. 43-48, 2018.
M. Ejaz Ahmed, Iyer, S., Thangavel, R., Kempuraj, D., Selvakumar, G. Pushpavath, Raikwar, S. P., Zaheer, S., and Zaheer, A., “Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
S. Yumoto, Kakimi, S., and Ishikawa, A., “Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1267-1281, 2018.
A. Espinosa, Alegret, M., Pesini, P., Valero, S., Lafuente, A., Buendia, M., San José, I., Ibarria, M., Tejero, M. A., Giménez, J., Ruiz, S., Hernandez, I., Pujadas, F., Martínez-Lage, P., Munuera, J., Arbizu, J., Tárraga, L., Hendrix, S. B., Ruiz, A., Becker, J. T., Landau, S. M., Sotolongo-Grau, O., Sarasa, M., and Boada, M., “Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.”, J Alzheimers Dis, vol. 57, no. 2, pp. 447-459, 2017.
J. M. Walker, Gonzales, M. M., Goette, W., Farrell, K., Iii, C. L. White, Crary, J. F., and Richardson, T. E., “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
R. Thangavel, Bhagavan, S. M., Ramaswamy, S. Beladakere, Surpur, S., Govindarajan, R., Kempuraj, D., Zaheer, S., Raikwar, S., Ahmed, M. E., Selvakumar, G. Pushpavath, Iyer, S. S., and Zaheer, A., “Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 61, no. 2, pp. 553-560, 2018.
E. Morenas-Rodriguez, Sala, I., Subirana, A., Pascual-Goñi, E., Sánchez-Saudinós, M. Belén, Alcolea, D., Illán-Gala, I., Carmona-Iragui, M., Ribosa-Nogué, R., Camacho, V., Blesa, R., Fortea, J., and Lleo, A., “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
L. Tariciotti, Casadei, M., Honig, L. S., Teich, A. F., Ii, G. M. McKhann, Tosto, G., and Mayeux, R., “Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1417-1425, 2018.
M. Isserles, Daskalakis, Z. J., Kumar, S., Rajji, T. K., and Blumberger, D. M., “Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia.”, J Alzheimers Dis, vol. 57, no. 1, pp. 45-51, 2017.

Pages